<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="mena-mig01/PMC6188058/results/search/mena-migration/results.xml">
  <result pre="with ERβ agonist displayed significant increase in cell proliferation and" exact="migration" post="when compared to controls. AA tissue samples from TNBC"/>
  <result pre="and β-actin was used for loading control. ERβ activation increases" exact="migration" post="and invasion in TNBC cells To determine the effect"/>
  <result pre="and 24h after incubation using phase-contrast microscope. The rate of" exact="migration" post="was measured by quantifying the total distance that the"/>
  <result pre="in increased cell migration. Figure 3 Activation of ERβ increases" exact="migration" post="of TNBC cells The cells were seeded in 8.5cm3"/>
  <result pre="here shows that activation of ERβ is involved in the" exact="migration" post="and invasion of TNBC cells. We then wanted to"/>
  <result pre="examined the role ERβ in disease progression, proliferation, invasion, and" exact="migration" post="of TNBC. Our findings show that contrary to previous"/>
  <result pre="the activation of ERβ in MB-231 cells, the inhibition of" exact="migration" post="(wound closure) due to ERβ activation didn't agree. Also,"/>
  <result pre="(DPN) and antagonist, 4-[2-phenyl-5,7-bis(trifluoromethyl)pyrazolo[1,5-a]-pyrimidin-3-yl]phenol (PHTPP) were purchased from Tocris. Cell" exact="migration" post="test TNBC cells were seeded in 8.5cm3 dishes and"/>
  <result pre="12, and 24hr. The wound area was marked and cell" exact="migration" post="into the scratched area was daily photographed using an"/>
  <result pre="cancer cellsGrowth Factors201129829310.3109/08977194.2011.56500321410323 35ManciniMGariboldiMBTaianaEBonziMCCraparottaIPaginMMontiECo-targeting the IGF system and HIF-1 inhibits" exact="migration" post="and invasion by (triple-negative) breast cancer cellsBr J Cancer201411028657310.1038/bjc.2014.26924853185"/>
 </snippets>
</snippetsTree>
